LivingGLP1
Study S002748

Prolongation of GLP-1 Adherence When Using Continuous Glucose Monitoring

ClinicalTrials.gov record

Registration

Registration
NCT06668935
Study type
OBSERVATIONAL
Status
RECRUITING
Enrollment
800
Start
2024-10-24
Primary completion
2026-10
Lead sponsor
Abbott Diabetes Care
Conditions
Diabetes Mellitus
Interventions
DEVICE:To utilize the FreeStyle Libre 3 Continuous Glucose Monitoring System (FSL3) to help prolong the length of time people with diabetes maintain adherence to GLP-1 and dual GIP/GLP-1 agonists
Results posted
FALSE
Individual participant data sharing
UNDECIDED

Registered primary outcomes

  • To assess the length of time subjects in each group remain on a GLP-1 or GLP-1/GIP combination drug [210 days]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.